Finance

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png https://www.investing.com/news/company-news/marketwise-receives-nasdaq-noncompliance-notice-93CH-3641558 Investing.com

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png https://www.investing.com/news/company-news/keros-therapeutics-completes-enrollment-for-tropos-trial-93CH-3641514 Investing.com

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png https://www.investing.com/news/company-news/kiromic-biopharma-issues-series-e-preferred-stock-in-debt-exchange-93CH-3641515 Investing.com

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png https://www.investing.com/news/company-news/adapthealth-clarifies-warrant-expiration-date-93CH-3641458 Investing.com

Christopher Anstey, Bloomberg

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/news/international_newspapers_69x52._800x533_L_1419494241.jpg https://www.investing.com/news/insider-trading-news/hagerty-director-kauffman-sells-shares-worth-nearly-148k-93CH-3641459 Investing.com

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/news/news_pile_69x52._800x533_L_1419494209.jpg https://www.investing.com/news/insider-trading-news/thoma-bravo-entities-sell-1263-million-of-meridianlink-shares-93CH-3641393 Investing.com

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png https://www.investing.com/news/company-news/td-synnex-adopts-new-bylaws-changes-board-voting-rules-93CH-3641397 Investing.com

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png https://www.investing.com/news/company-news/savara-shares-hold-outperform-rating-15-target-on-molbreevi-prospects-93CH-3641346 Investing.com